Topics

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

2019-09-19 03:56:45 | BioPortfolio

Summary

This is a prospective, randomized, controlled, single blind, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients

Study Design

Conditions

Heart Failure NYHA Class III

Intervention

Cordella™ Pulmonary Artery Sensor System, Cordella™ Pulmonary Artery Sensor System

Status

Not yet recruiting

Source

Endotronix, Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-09-19T03:56:45-0400

Clinical Trials [7136 Associated Clinical Trials listed on BioPortfolio]

SIRONA 2 Trial Heart Failure NYHA Class III

This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Cordella PA Sensor System in 60 New York Heart Association (NYHA) Clas...

SIRONA Trial Heart Failure NYHA Class III

This is a prospective, multi-center, open-label, single-arm feasibility trial to assess device safety and efficacy of the Cordella™ Heart Failure System in 10 NYHA Class III heart failur...

PRODIGY Registry in NYHA Class III Heart Failure Patients

This is an observational, prospective, single arm, multi-center registry to evaluate the Cordella™ Heart Failure System (CHFS) in up to 250 NYHA Class III HF patients .

Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation

Pulmonary artery rehabilitation procedure is done frequently in the catheterization suite for patients with pulmonary artery stenosis or small pulmonary arteries following surgical repair ...

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal

This study will evaluate an implantable pulmonary artery pressure sensor in patients with heart failure.

PubMed Articles [13740 Associated PubMed Articles listed on BioPortfolio]

Internal Jugular Vein as Alternative Access for Implantation of a Wireless Pulmonary Artery Pressure Sensor.

A wireless pulmonary artery pressure sensor (CardioMEMS) is approved for implantation via the femoral vein. The internal jugular vein (IJ) is an attractive alternative access route commonly used in pu...

Norwood Operation with Anterior Translocation of Pulmonary Artery.

Even in the current era of improved clinical outcome of Norwood operation, postoperative pulmonary artery stenosis, recoarctation of the aorta, ventricular dysfunction, and atrioventricular valve regu...

Reverse Remodeling of Pulmonary Arterioles After Pulmonary Artery Banding in Patients ≥ 2 Years Old with Severe Pulmonary Arterial Hypertension and Congenital Heart Disease.

The purpose of this study was to evaluate the pathological changes of the pulmonary arterioles in patients ≥ 2 years of age who first underwent a pulmonary artery banding (PAB) procedure, followed...

Absence of the fetal right pulmonary artery complicated with coarctation of the aorta: Prenatal and postnatal diagnosis.

Unilateral absence of the pulmonary artery (UAPA) is a rare congenital cardiovascular malformation that can present as an isolated lesion or may be associated with other congenital heart malformations...

Complex lobectomy in a patient with lung cancer and pulmonary artery sling.

Pulmonary artery sling is a rare congenital anomaly of the origin and course of the left pulmonary artery. This condition typically presents with respiratory failure in young infancy, while asymptomat...

Medical and Biotech [MESH] Definitions

Placement of a balloon-tipped catheter into the pulmonary artery through the antecubital, subclavian, and sometimes the femoral vein. It is used to measure pulmonary artery pressure and pulmonary artery wedge pressure which reflects left atrial pressure and left ventricular end-diastolic pressure. The catheter is threaded into the right atrium, the balloon is inflated and the catheter follows the blood flow through the tricuspid valve into the right ventricle and out into the pulmonary artery.

Narrowing below the PULMONARY VALVE or well below it in the infundibuluar chamber where the pulmonary artery originates, usually caused by a defective VENTRICULAR SEPTUM or presence of fibrous tissues. It is characterized by restricted blood outflow from the RIGHT VENTRICLE into the PULMONARY ARTERY, exertional fatigue, DYSPNEA, and chest discomfort.

Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.

The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES.

Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.

More From BioPortfolio on "PROACTIVE-HF IDE Trial Heart Failure NYHA Class III"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Searches Linking to this Trial